Publikationen von M. Theodoropoulou
Alle Typen
Zeitschriftenartikel (80)
2012
Zeitschriftenartikel
73 (2), S. 71 - 72 (2012)
A general overview on pituitary tumorigenesis. Annales d' Endocrinologie
Zeitschriftenartikel
19 (1), S. 13 - 27 (2012)
RSUME is implicated in HIF-1-induced VEGF-A production in pituitary tumour cells. Endocrine-Related Cancer 2011
Zeitschriftenartikel
22 (21), S. 4182 - 4191 (2011)
The SHP-1 protein tyrosine phosphatase negatively modulates Akt signaling in the ghrelin/GHSR1a system. Molecular Biology of the Cell
Zeitschriftenartikel
165 (4), S. 509 - 515 (2011)
High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas. European Journal of Endocrinology
Zeitschriftenartikel
10 (8), S. 1450 - 1459 (2011)
Levels of p27 Sensitize to Dual PI3K/mTOR Inhibition. Molecular Cancer Therapeutics
Zeitschriftenartikel
94 (2), S. 124 - 136 (2011)
Effect of SOM230 (Pasireotide) on Corticotropic Cells: Action in Dogs with Cushing's Disease. Neuroendocrinology 2010
Zeitschriftenartikel
326 (1-2), S. 60 - 65 (2010)
ZAC1 target genes and pituitary tumorigenesis. Molecular and Cellular Endocrinology
Zeitschriftenartikel
70 (14), S. 6026 - 6035 (2010)
Loss of Function of the Tumor Suppressor DKC1 Perturbs p27 Translation Control and Contributes to Pituitary Tumorigenesis. Cancer Research
Zeitschriftenartikel
70 (2), S. 666 - 674 (2010)
The Somatostatin Analogue Octreotide Confers Sensitivity to Rapamycin Treatment on Pituitary Tumor Cells. Cancer Research 2009
Zeitschriftenartikel
117 (10), S. 657 - 657 (2009)
Octreotide enhances rapamycin's antiproliferative action by inhibiting rapamycin-induced IRS-1 and Akt activation. Experimental and Clinical Endocrinology & Diabetes
Zeitschriftenartikel
117 (10), S. 656 - 656 (2009)
NOD2 receptors in adenopituitary folliculostellate cells: expression and function. Experimental and Clinical Endocrinology & Diabetes
Zeitschriftenartikel
117 (10), S. 656 - 656 (2009)
Activation of NOD and TLR4 innate immune receptors in tumoral pituitary cells and their effects on downstream targets. Experimental and Clinical Endocrinology & Diabetes
Zeitschriftenartikel
117 (10), S. 657 - 657 (2009)
Expression, regulation and function of HIF-1 alpha and RSUME in murine and human pituitary tumor cells. Experimental and Clinical Endocrinology & Diabetes
Zeitschriftenartikel
117 (10), S. 657 - 658 (2009)
CB1 cannabinoid receptor positively regulates pro-opiomelanocortin (POMC) transcription through activation of the cAMP-response element (CRE)-binding protein (CREB). Experimental and Clinical Endocrinology & Diabetes
Zeitschriftenartikel
125 (9), S. 2122 - 2126 (2009)
Tumor ZAC1 expression is associated with the response to somatostatin analog therapy in patients with acromegaly. International Journal of Cancer
Zeitschriftenartikel
203 (1), S. 111 - 122 (2009)
NOD2 receptors in adenopituitary folliculostellate cells: expression and function. Journal of Endocrinology
Zeitschriftenartikel
16 (3), S. 1017 - 1027 (2009)
Mammalian target of rapamycin inhibitors rapamycin and RAD001 (everolimus) induce anti-proliferative effects in GH-secreting pituitary tumor cells in vitro. Endocrine-Related Cancer
Zeitschriftenartikel
16 (3), S. 1029 - 1043 (2009)
Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications. Endocrine-Related Cancer
Zeitschriftenartikel
16 (2), S. 599 - 611 (2009)
Obestatin stimulates Akt signalling in gastric cancer cells through beta-arrestin-mediated epidermal growth factor receptor transactivation. Endocrine-Related Cancer
Zeitschriftenartikel
16 (3), S. 208 - 212 (2009)
Modulation of Growth Hormone and Prolactin Secretion in Trypanosoma cruzi-Infected Mammosomatotrophic Cells. Neuroimmunomodulation